Actinogen Medical (ASX:ACW) has launched a buy-back of its ordinary fully paid shares under a new employee share scheme, according to a Thursday Australian bourse filing.
The company proposed to buy back a maximum of around 2.8 million of its ordinary shares, per the filing.
The buy-back is expected to commence on April 28, the filing added.
The company's shares fell 3% in recent Thursday trade.